About Suven Pharmaceuticals Limited
Data last updated: 15 February 2022
Suven Pharmaceuticals Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Jasti Property And Equity Holdings Private Limited. It specialises in pharmaceutical formulations, a part of the broader pharmaceuticals sector. Incorporated on 06 November 2018, the company has been in operation for over 8 years.
Registered with ROC Hyderabad under CIN U24299TG2018PLC128171. Listed on BSE: 543064 and NSE: SUVENPHAR.
Capital: an authorised share capital of ₹40 Cr and a paid-up capital of ₹25.46 Cr. It is led by director Jerry Jeyasingh.
Last AGM: 31 August 2021. Financial statements filed for year ended 31 March 2021. Office: Hyderabad, Telangana.
As per the financials filed for FY 2022, the company reported a revenue of ₹1,508.01 Cr, a growth of 47.27% compared to the previous year.
The company has a workforce of approximately 943 employees as per the latest available data. It operates as a subsidiary of Jasti Property And Equity Holdings Private Limited.
The company is associated with 1 brand - Suven Pharma. As per MCA filings, the company has open charges of ₹174.02 Cr on record.
For more details, the company can be reached via its website suvenpharm.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address# 8 – 2 – 334 Sde Serene Chambers 3Rd Floor, Avenue 7 Road No. 5 Banjara Hills, Hyderabad, Telangana, India – 500034
-
IndustryPharma, Pharmaceutical Formulations
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited has one previous CIN (Corporate Identification Number): L24299TG2018PLC128171. The current CIN is U24299TG2018PLC128171, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24299TG2018PLC128171 | Current |
| L24299TG2018PLC128171 | Previous |
Associated Brands with Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited operates one associated brand: Suven Pharma. These brands represent Suven Pharmaceuticals Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Contract manufacturing and development of APIs and formulations are provided. | suvenpharm.com |
Competitors & Alternatives of Suven Pharmaceuticals Limited
Brands and companies operating in the same space as Suven Pharmaceuticals Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
BDR Pharmaceuticals Internationals
|
APIs and finished products are developed and manufactured. | Mumbai, India, India | 2003 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Aurobindo Pharma
|
Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India, India | 1986 |
Seqens
|
Contract manufacturing services for small molecules and peptides are provided. | Ecully, France, France | 2003 |
Asymchem
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
Aptuit
|
Contract research and development services for small molecules are offered. | Greenwich, United States, United States | 2004 |
Continuus Pharma
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Business Activity of Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Detailed business activity records for Suven Pharmaceuticals Limited
Activity codes and turnover contribution percentages require an active report plan.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Auditor Details of Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited is audited by KARVY & CO for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KARVY & CO | Locked | Locked | Locked |
Complete auditor history for Suven Pharmaceuticals Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited is currently managed by 1 director, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jerry Jeyasingh | Director | 06 Nov 2019 | 6 Years 8 Months | Current |
Financials of Suven Pharmaceuticals Limited FY 2021 filings available
Suven Pharmaceuticals Limited reported revenue of ₹1,508.01 Cr (up 47.27% YoY) for FY 2022.
Ten-year financial statements for Suven Pharmaceuticals Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Suven Pharmaceuticals Limited
Shareholding and ownership data for Suven Pharmaceuticals Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Suven Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 2020 | Bank of Bahrain and Kuwait Bsc | ₹10 Cr | Open |
| 05 Nov 2020 | State Bank of India | ₹164.02 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited has a workforce of 877 employees as of Apr 06, 2024.
Employee and EPFO history for Suven Pharmaceuticals Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Suven Pharmaceuticals Limited
GST registrations and filing compliance for Suven Pharmaceuticals Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Suven Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts for Suven Pharmaceuticals Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Suven Pharmaceuticals Limited
MSME payment history for Suven Pharmaceuticals Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Suven Pharmaceuticals Limited
Corporate group structure for Suven Pharmaceuticals Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Suven Pharmaceuticals Limited
MCA filings and documents for Suven Pharmaceuticals Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Suven Pharmaceuticals Limited
Recent News on Suven Pharmaceuticals Limited
Frequently Asked Questions about Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 06 November 2018 (8+ years old) and is registered under CIN U24299TG2018PLC128171. Listed on BSE: 543064 and NSE: SUVENPHAR. The company has 943 employees.
Suven Pharmaceuticals Limited reported revenue of ₹1,508.01 Cr for FY 2022 (up 47.27% YoY).
The current directors of Suven Pharmaceuticals Limited are:
- Jerry Jeyasingh - Director
The primary industry of Suven Pharmaceuticals Limited is pharma. The company specifically operates in pharmaceutical formulations. The company is currently active in this sector.
Yes. Suven Pharmaceuticals Limited is listed on both BSE (code: 543064) and NSE (symbol: SUVENPHAR).
Suven Pharmaceuticals Limited can be reached at the registered office: # 8 – 2 – 334 Sde Serene Chambers 3Rd Floor, Avenue 7 Road No. 5 Banjara Hills, Hyderabad, Telangana, India – 500034, or through the website suvenpharm.com.